- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
Study links long-term formaldehyde exposure and myeloid leukemia
A new study published in the Journal of the National Cancer Institute adds further weight to the risk of death from myeloid leukemia for people who work with the chemical compound formaldehyde for an extended period of time, including anatomists, pathologists, and funeral industry workers
Although formaldehyde has long been known as a human carcinogen, this is the first known study to conclude that the embalming chemical's potential role in the development and death from lymphohematopoietic malignancies is statistically significant over a long period of time (more than 20 years).
The study was carried out by researchers at the Division of Cancer Epidemiology and Genetics at the National Cancer Institute in Bethesda, Md.
According to the study's authors, "This study adds supporting and complementary data to other epidemiological evidence of an association between formaldehyde exposure and risk of myeloid leukemia."
Source: Medical News Today